These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23753416)

  • 1. The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis.
    Yakoob MY; Bateman BT; Ho E; Hernandez-Diaz S; Franklin JM; Goodman JE; Hoban RA
    Hypertension; 2013 Aug; 62(2):375-81. PubMed ID: 23753416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control Study.
    Bergman JEH; Lutke LR; Gans ROB; Addor MC; Barisic I; Cavero-Carbonell C; Garne E; Gatt M; Klungsoyr K; Lelong N; Lynch C; Mokoroa O; Nelen V; Neville AJ; Pierini A; Randrianaivo H; Rissmann A; Tucker D; Wiesel A; Dolk H; Loane M; Bakker MK
    Drug Saf; 2018 Apr; 41(4):415-427. PubMed ID: 29230691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of congenital malformations in offspring of women using β-blockers during early pregnancy: An updated meta-analysis of observational studies.
    Wu Y; Yao JW; Xu LJ; Chen M; Wan L
    Br J Clin Pharmacol; 2021 Mar; 87(3):806-815. PubMed ID: 32978831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Blocker Use in Pregnancy and the Risk for Congenital Malformations: An International Cohort Study.
    Bateman BT; Heide-Jørgensen U; Einarsdóttir K; Engeland A; Furu K; Gissler M; Hernandez-Diaz S; Kieler H; Lahesmaa-Korpinen AM; Mogun H; Nørgaard M; Reutfors J; Selmer R; Huybrechts KF; Zoega H
    Ann Intern Med; 2018 Nov; 169(10):665-673. PubMed ID: 30326014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza and congenital anomalies: a systematic review and meta-analysis.
    Luteijn JM; Brown MJ; Dolk H
    Hum Reprod; 2014 Apr; 29(4):809-23. PubMed ID: 24365800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal corticosteroid use and risk of selected congenital anomalies.
    Carmichael SL; Shaw GM
    Am J Med Genet; 1999 Sep; 86(3):242-4. PubMed ID: 10482873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Proton Pump Inhibitor Use During Early Pregnancy and Risk of Congenital Malformations.
    Choi A; Noh Y; Jeong HE; Choi EY; Man KKC; Han JY; Kim HS; Yon DK; Shin JY
    JAMA Netw Open; 2023 Jan; 6(1):e2250366. PubMed ID: 36626173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies.
    Dolovich LR; Addis A; Vaillancourt JM; Power JD; Koren G; Einarson TR
    BMJ; 1998 Sep; 317(7162):839-43. PubMed ID: 9748174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital malformation and maternal occupational exposure to glycol ethers. Occupational Exposure and Congenital Malformations Working Group.
    Cordier S; Bergeret A; Goujard J; Ha MC; Aymé S; Bianchi F; Calzolari E; De Walle HE; Knill-Jones R; Candela S; Dale I; Dananché B; de Vigan C; Fevotte J; Kiel G; Mandereau L
    Epidemiology; 1997 Jul; 8(4):355-63. PubMed ID: 9209847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring.
    Huybrechts KF; Hernández-Díaz S; Straub L; Gray KJ; Zhu Y; Patorno E; Desai RJ; Mogun H; Bateman BT
    JAMA; 2018 Dec; 320(23):2429-2437. PubMed ID: 30561479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.
    Jentink J; Dolk H; Loane MA; Morris JK; Wellesley D; Garne E; de Jong-van den Berg L;
    BMJ; 2010 Dec; 341():c6581. PubMed ID: 21127116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study.
    Li DK; Yang C; Andrade S; Tavares V; Ferber JR
    BMJ; 2011 Oct; 343():d5931. PubMed ID: 22010128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of asthma medication during pregnancy and risk of specific congenital anomalies: A European case-malformed control study.
    Garne E; Hansen AV; Morris J; Zaupper L; Addor MC; Barisic I; Gatt M; Lelong N; Klungsøyr K; O'Mahony M; Nelen V; Neville AJ; Pierini A; Tucker D; de Walle H; Wiesel A; Loane M; Dolk H
    J Allergy Clin Immunol; 2015 Dec; 136(6):1496-1502.e7. PubMed ID: 26220526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major congenital malformations after first-trimester exposure to ACE inhibitors.
    Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA
    N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.
    Anderka M; Mitchell AA; Louik C; Werler MM; Hernández-Diaz S; Rasmussen SA;
    Birth Defects Res A Clin Mol Teratol; 2012 Jan; 94(1):22-30. PubMed ID: 22102545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies.
    Shen ZQ; Gao SY; Li SX; Zhang TN; Liu CX; Lv HC; Zhang Y; Gong TT; Xu X; Ji C; Wu QJ; Li D
    Br J Clin Pharmacol; 2017 Apr; 83(4):909-922. PubMed ID: 27770542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.
    Bérard A; Iessa N; Chaabane S; Muanda FT; Boukhris T; Zhao JP
    Br J Clin Pharmacol; 2016 Apr; 81(4):589-604. PubMed ID: 26613360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis.
    Ingrid Goh Y; Bollano E; Einarson TR; Koren G
    J Obstet Gynaecol Can; 2006 Aug; 28(8):680-689. PubMed ID: 17022907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis.
    Cassina M; Donà M; Di Gianantonio E; Litta P; Clementi M
    Hum Reprod Update; 2014; 20(5):656-69. PubMed ID: 24861556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of malformation after ondansetron in pregnancy: An updated systematic review and meta-analysis.
    Picot C; Berard A; Grenet G; Ripoche E; Cucherat M; Cottin J
    Birth Defects Res; 2020 Aug; 112(13):996-1013. PubMed ID: 32420702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.